Health In Tech Statistics
Total Valuation
Health In Tech has a market cap or net worth of $59.35 million. The enterprise value is $52.94 million.
| Market Cap | 59.35M |
| Enterprise Value | 52.94M |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health In Tech has 65.53 million shares outstanding. The number of shares has increased by 3.76% in one year.
| Current Share Class | 53.83M |
| Shares Outstanding | 65.53M |
| Shares Change (YoY) | +3.76% |
| Shares Change (QoQ) | +9.55% |
| Owned by Insiders (%) | 68.68% |
| Owned by Institutions (%) | 7.26% |
| Float | 20.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.81 |
| Forward PS | 1.05 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | 18.94 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 16.89 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.18 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -21.91% and return on invested capital (ROIC) is -42.86%.
| Return on Equity (ROE) | -21.91% |
| Return on Assets (ROA) | -12.72% |
| Return on Invested Capital (ROIC) | -42.86% |
| Return on Capital Employed (ROCE) | -26.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $360,736 |
| Profits Per Employee | -$43,403 |
| Employee Count | 91 |
| Asset Turnover | 1.27 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -66.08% |
| 50-Day Moving Average | 1.04 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 33.74 |
| Average Volume (20 Days) | 75,944 |
Short Selling Information
The latest short interest is 439,926, so 0.67% of the outstanding shares have been sold short.
| Short Interest | 439,926 |
| Short Previous Month | 497,437 |
| Short % of Shares Out | 0.67% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 7.57 |
Income Statement
In the last 12 months, Health In Tech had revenue of $32.83 million and -$3.95 million in losses. Loss per share was -$0.07.
| Revenue | 32.83M |
| Gross Profit | 17.70M |
| Operating Income | -5.27M |
| Pretax Income | -5.23M |
| Net Income | -3.95M |
| EBITDA | n/a |
| EBIT | -5.27M |
| Loss Per Share | -$0.07 |
Balance Sheet
The company has $6.51 million in cash and $102,938 in debt, with a net cash position of $6.41 million or $0.10 per share.
| Cash & Cash Equivalents | 6.51M |
| Total Debt | 102,938 |
| Net Cash | 6.41M |
| Net Cash Per Share | $0.10 |
| Equity (Book Value) | 19.62M |
| Book Value Per Share | 0.30 |
| Working Capital | 11.80M |
Cash Flow
| Operating Cash Flow | -5.11M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 3.13M |
| FCF Per Share | $0.05 |
Margins
Gross margin is 53.93%, with operating and profit margins of -16.07% and -12.03%.
| Gross Margin | 53.93% |
| Operating Margin | -16.07% |
| Pretax Margin | -15.94% |
| Profit Margin | -12.03% |
| EBITDA Margin | n/a |
| EBIT Margin | -16.07% |
| FCF Margin | 9.55% |
Dividends & Yields
Health In Tech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.76% |
| Shareholder Yield | -3.76% |
| Earnings Yield | -6.65% |
| FCF Yield | 5.28% |
Analyst Forecast
The average price target for Health In Tech is $3.70, which is 308.52% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.70 |
| Price Target Difference | 308.52% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health In Tech has an Altman Z-Score of 7.42.
| Altman Z-Score | 7.42 |
| Piotroski F-Score | n/a |